September 1, 2016 – By  Carolyn LaWell Disc Replacement Zimmer Biomet’s $1 billion acquisition of LDR and its Mobi-C cervical disc assets and Medtronic’s FDA Premarket Approval for the Prestige LP 2-level application changed the game in the U.S. 2-level cervical disc replacement arena. Mobi-C had been the only 2-level disc approved on the U.S. market. Prior […]